Perindopril for improving cardiovascular events

Vasc Health Risk Manag. 2014 Aug 30:10:539-48. doi: 10.2147/VHRM.S68384. eCollection 2014.

Authors

James J DiNicolantonio¹, James H O'Keefe¹

Affiliation

¹ Department of Preventive Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.

No abstract available

Publication types

Letter
Comment

MeSH terms

Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Antihypertensive Agents / therapeutic use*
Benzimidazoles / therapeutic use*
Benzoates / therapeutic use*
Blood Pressure / drug effects*
Humans
Hypertension / drug therapy*
Perindopril / therapeutic use*

Substances

Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Benzimidazoles
Benzoates
Perindopril